Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Centessa Pharmaceuticals is a clinical-stage biotech focused on discovering and developing transformative medicines, including orexin receptor 2 (OX2R) agonists for sleep and neurodegenerative disorders, and innovative immuno-oncology therapies using its LockBody platform. It targets neurological, neuropsychiatric, and cancer indications, leveraging proprietary technology and strategic licensing. The company relies on third-party manufacturing, collaborates with partners, and navigates complex regulatory pathways to bring novel treatments to market.
This description was generated via AI from an annual report. Updated about 1 year ago.